stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Revenue growth
Sotera Health Company's revenue growth over the twelve months to 30 September 2026 was 6.90%, up 1.2 percentage points from fiscal 2025 (5.74%). Over the past ten years it has ranged from −4.13% (fiscal 2018) to 13.9% (fiscal 2021); the current reading is higher than 75% of that period. That is below the Diagnostics & Research industry median of 8.99% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.74% | 0.86 |
| FY2024 | 4.88% | 0.34 |
| FY2023 | 4.54% | (3.21) |
| FY2022 | 7.75% | (6.10) |
| FY2021 | 13.9% | 8.73 |
| FY2020 | 5.12% | 0.81 |
| FY2019 | 4.31% | 8.44 |
| FY2018 | −4.13% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 4.36% | (4.82) |
| Jun 2026 | 9.18% | (0.85) |
| Mar 2026 | 10.0% | 5.47 |
| Dec 2025 | 4.56% | (4.49) |
| 24 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BLLN BillionToOne, Inc. compare | 76.5% |
| CDNA CareDx, Inc. compare | 38.9% |
| RDNT RadNet, Inc. compare | 18.9% |
| ADPT Adaptive Biotechnologies Corporation compare | 17.9% |
| VCYT Veracyte, Inc. compare | 17.5% |
| GRAL GRAIL, Inc. compare | 17.5% |
| NEO NeoGenomics, Inc. compare | 11.1% |
| SHC Sotera Health Company | 6.90% |
| QGEN QIAGEN N.V. compare | 2.96% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on SHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement